These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28629197)

  • 1. Reply to the Letter to the Editor by C. Nicolazzo et al.: "Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy".
    Alama A; Coco S; Vanni I; Grossi F
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter to the Editor: "Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy".
    Nicolazzo C; Raimondi C; Loreni F; Gazzaniga P; Gradilone A
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
    Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
    Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
    Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Biomarkers in Non-Small-Cell Lung Cancer: Current Status and Future Challenges.
    Matikas A; Syrigos KN; Agelaki S
    Clin Lung Cancer; 2016 Nov; 17(6):507-516. PubMed ID: 27373516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible applications of circulating tumor cells in patients with non small cell lung cancer.
    Tartarone A; Rossi E; Lerose R; Mambella G; Calderone G; Zamarchi R; Aieta M
    Lung Cancer; 2017 May; 107():59-64. PubMed ID: 27339469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
    Kawaishi M; Fujiwara Y; Fukui T; Kato T; Yamada K; Ohe Y; Kunitoh H; Sekine I; Yamamoto N; Nokihara H; Watabe T; Shimoda Y; Arao T; Nishio K; Tamura T; Koizumi F
    J Thorac Oncol; 2009 Feb; 4(2):208-13. PubMed ID: 19179898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and Monitoring of the BRAF Mutation in Circulating Tumor Cells and Circulating Tumor DNA in BRAF-Mutated Lung Adenocarcinoma.
    Guibert N; Pradines A; Casanova A; Farella M; Keller L; Soria JC; Favre G; Mazières J
    J Thorac Oncol; 2016 Sep; 11(9):e109-12. PubMed ID: 27165943
    [No Abstract]   [Full Text] [Related]  

  • 9. [Research progress of circulating tumor DNA methylation in non-small cell lung cancer].
    Yang Lan L; Chen Bojiang BJ; Li Lei L
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Dec; 41(12):967-970. PubMed ID: 30522195
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictive and prognostic significance of circulating endothelial cells in advanced non-small cell lung cancer patients.
    Yuan DM; Zhang Q; Lv YL; Ma XQ; Zhang Y; Liu HB; Song Y
    Tumour Biol; 2015 Nov; 36(11):9031-7. PubMed ID: 26084612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages.
    Guibert N; Pradines A; Favre G; Mazieres J
    Eur Respir Rev; 2020 Mar; 29(155):. PubMed ID: 32051167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor cells count as a predictor of survival in lung cancer.
    Syrigos K; Fiste O; Charpidou A; Grapsa D
    Crit Rev Oncol Hematol; 2018 May; 125():60-68. PubMed ID: 29650278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating levels of soluble intercellular adhesion molecule-1 in non-small cell lung cancer patients.
    De Vita F; Infusino S; Auriemma A; Orditura M; Catalano G
    Oncol Rep; 1998; 5(2):393-6. PubMed ID: 9468565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.
    Bracht JWP; Mayo-de-Las-Casas C; Berenguer J; Karachaliou N; Rosell R
    Curr Oncol Rep; 2018 Jul; 20(9):70. PubMed ID: 30030656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Utility of Liquid Diagnostic Platforms in Non-Small Cell Lung Cancer.
    Levy B; Hu ZI; Cordova KN; Close S; Lee K; Becker D
    Oncologist; 2016 Sep; 21(9):1121-30. PubMed ID: 27388233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
    Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J
    Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating endothelial cells as a biomarker in non-small cell lung cancer patients: correlation with clinical outcome.
    Najjar F; Alammar M; Bachour M; Al-Massarani G
    Int J Biol Markers; 2014 Dec; 29(4):e337-44. PubMed ID: 25041783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating cell-free DNA as a diagnostic and prognostic biomarker for non-small-cell lung cancer: a systematic review and meta-analysis.
    Chen Z; Miao H; Zeng Q; Xu S; Chen Z; Liu K
    Biomark Med; 2020 May; 14(7):587-597. PubMed ID: 31845833
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictive and prognostic value of circulating tumor cell detection in lung cancer: a clinician's perspective.
    Tognela A; Spring KJ; Becker T; Caixeiro NJ; Bray VJ; Yip PY; Chua W; Lim SH; de Souza P
    Crit Rev Oncol Hematol; 2015 Feb; 93(2):90-102. PubMed ID: 25459665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.
    Chakra M; Pujol JL; Lamy PJ; Bozonnat MC; Quantin X; Jacot W; Daurès JP
    J Thorac Oncol; 2008 Oct; 3(10):1119-26. PubMed ID: 18827607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.